{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:27Z","timestamp":1760132487403,"version":"3.37.3"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001547","name":"China Medical Board","doi-asserted-by":"publisher","award":["12-114"],"award-info":[{"award-number":["12-114"]}],"id":[{"id":"10.13039\/100001547","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH research training grant","award":["#R25 TW009345"],"award-info":[{"award-number":["#R25 TW009345"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.schres.2018.05.014","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T03:24:05Z","timestamp":1527305045000},"page":"307-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China"],"prefix":"10.1016","volume":"201","author":[{"given":"Dong (Roman)","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7943-4041","authenticated-orcid":false,"given":"Wenjie","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Gloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Caine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuiyuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bofeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.schres.2018.05.014_bb0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2008.09.007","article-title":"Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS\u00ae) and its relationship to sociodemographic, clinical and psychopathological variables","volume":"107","author":"Acosta","year":"2009","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2018.05.014_bb0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/19.3.609","article-title":"Subjective response to neuroleptics in schizophrenia","volume":"19","author":"Awad","year":"1993","journal-title":"Schizophr. Bull."},{"issue":"Suppl. 4","key":"10.1016\/j.schres.2018.05.014_bb0015","first-page":"1","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Bellack","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"8476","key":"10.1016\/j.schres.2018.05.014_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"327","author":"Bland","year":"1986","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.schres.2018.05.014_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat. Methods Med. Res."},{"issue":"2","key":"10.1016\/j.schres.2018.05.014_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.euroneuro.2013.11.013","article-title":"Twelve months of electronic monitoring (MEMS\u00ae) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia","volume":"24","author":"Brain","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2018.05.014_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psychres.2004.11.002","article-title":"A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia","volume":"133","author":"Byerly","year":"2005","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.schres.2018.05.014_bb0040","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/ps.2007.58.6.844","article-title":"Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia","volume":"58","author":"Byerly","year":"2007","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.schres.2007.12.470","article-title":"The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder","volume":"100","author":"Byerly","year":"2008","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/JCP.0b013e3181ca03df","article-title":"A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis","volume":"30","author":"Cassidy","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ. Psychol. Meas."},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005053-199901000-00009","article-title":"Enhancing medication compliance for people with serious mental illness","volume":"187","author":"Cramer","year":"1999","journal-title":"J. Nerv. Ment. Dis."},{"issue":"22","key":"10.1016\/j.schres.2018.05.014_bb0065","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.1989.03420220087032","article-title":"How often is medication taken as prescribed?: a novel assessment technique","volume":"261","author":"Cramer","year":"1989","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016982","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review","volume":"8","author":"Cutler","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.schres.2018.05.014_bb0075","series-title":"The Beijing News","article-title":"Ministry of health and family planning: number of people with psychosis under management reached 5.4 million in 2016 in China","author":"Dandan","year":"2017"},{"key":"10.1016\/j.schres.2018.05.014_bb0080","series-title":"Patient Preference and Adherence","first-page":"275","article-title":"Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia","volume":"7","author":"Dilla","year":"2013"},{"issue":"4","key":"10.1016\/j.schres.2018.05.014_bb0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.jcp.0000130554.63254.3a","article-title":"Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence","volume":"24","author":"Dolder","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.05.014_bb0090","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00005650-199010000-00003","article-title":"The effects of monitoring and feedback on compliance","author":"Elixhauser","year":"1990","journal-title":"Med. Care"},{"issue":"6","key":"10.1016\/j.schres.2018.05.014_bb0095","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin. Ther."},{"key":"10.1016\/j.schres.2018.05.014_bb0100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2147\/NDT.S40777","article-title":"Tackling nonadherence in psychiatric disorders: current opinion","volume":"10","author":"Farooq","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.schres.2018.05.014_bb0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1192\/bjp.bp.110.085340","article-title":"Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS)","volume":"199","author":"Farooq","year":"2011","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2007.10.029","article-title":"A large-scale validation study of the Medication Adherence Rating Scale (MARS)","volume":"100","author":"Fialko","year":"2008","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2018.05.014_bb0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mlr.0000129496.05898.02","article-title":"The concordance of self-report with other measures of medication adherence: a summary of the literature","volume":"42","author":"Garber","year":"2004","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010120","article-title":"Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial","volume":"6","author":"Xu","year":"2016","journal-title":"BMJ Open"},{"issue":"7\u20138","key":"10.1016\/j.schres.2018.05.014_bb0125","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1345\/aph.17423","article-title":"Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly","volume":"32","author":"Grymonpre","year":"1998","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.schres.2018.05.014_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1345\/aph.1L496","article-title":"Adherence: comparison of methods to assess medication adherence and classify nonadherence","volume":"43","author":"Hansen","year":"2009","journal-title":"Ann. Pharmacother."},{"issue":"s416","key":"10.1016\/j.schres.2018.05.014_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The clinical global impression\u2013schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","volume":"107","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.schres.2018.05.014_bb0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291700050182","article-title":"A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity","volume":"13","author":"Hogan","year":"1983","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.schres.2018.05.014_bb0150","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.4088\/JCP.12m08222","article-title":"First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder","volume":"74","author":"Kane","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2018.05.014_bb0155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2018.05.014_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S1461145703003389","article-title":"Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia","volume":"6","author":"Kinon","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2018.05.014_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.31887\/DCNS.2016.18.2\/jkreyenbuhl","article-title":"A review of behavioral tailoring strategies for improving medication adherence in serious mental illness","volume":"18","author":"Kreyenbuhl","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"issue":"30","key":"10.1016\/j.schres.2018.05.014_bb0180","first-page":"515","article-title":"Concordance analysis: part 16 of a series on evaluation of scientific publications","volume":"108","author":"Kwiecien","year":"2011","journal-title":"Dtsch Arztebl Int"},{"issue":"10","key":"10.1016\/j.schres.2018.05.014_bb0185","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2018.05.014_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.schres.2018.05.014_bb0195","first-page":"599","article-title":"Assay validation using the concordance correlation coefficient","author":"Lawrence","year":"1992","journal-title":"Biometrics"},{"key":"10.1016\/j.schres.2018.05.014_bb0200","first-page":"3","article-title":"Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia","volume":"67","author":"Leucht","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2018.05.014_bb0205","series-title":"The Cochrane Library","article-title":"Maintenance treatment with antipsychotic drugs for schizophrenia","author":"Leucht","year":"2012"},{"issue":"9831","key":"10.1016\/j.schres.2018.05.014_bb0210","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2018.05.014_bb0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility","volume":"45","author":"Lin","year":"1989","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.schres.2018.05.014_bb0220","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/j.2051-5545.2011.tb00059.x","article-title":"Mental health system in China: history, recent service reform and future challenges","volume":"10","author":"Liu","year":"2011","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.psychres.2007.05.001","article-title":"Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity","volume":"157","author":"Nakonezny","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2018.05.014_bb0240","series-title":"The Cochrane Library","article-title":"Interventions for enhancing medication adherence","author":"Nieuwlaat","year":"2014"},{"issue":"7","key":"10.1016\/j.schres.2018.05.014_bb0245","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1017\/S0033291703008328","article-title":"How often do patients with psychosis fail to adhere to treatment programmes? A systematic review","volume":"33","author":"Nose","year":"2003","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.schres.2018.05.014_bb0255","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/schbul\/sbv107","article-title":"Universal health coverage for schizophrenia: a global mental health priority","volume":"42","author":"Patel","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0260","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.schres.2006.11.015","article-title":"The use of electronic monitoring (MEMS\u00ae) to evaluate antipsychotic compliance in outpatients with schizophrenia","volume":"90","author":"Remington","year":"2007","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2018.05.014_bb0270","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpsychores.2009.05.007","article-title":"Measurement of psychiatric treatment adherence","volume":"69","author":"Sajatovic","year":"2010","journal-title":"J. Psychosom. Res."},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0275","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psychres.2014.11.002","article-title":"A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders","volume":"225","author":"Sendt","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2018.05.014_bb0280","series-title":"Patient Preference and Adherence","first-page":"1071","article-title":"Access to credible information on schizophrenia patients' medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers","volume":"11","author":"Shafrin","year":"2017"},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0285","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1477-7525-8-99","article-title":"Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis","volume":"8","author":"Shi","year":"2010","journal-title":"Health Qual. Life Outcomes"},{"issue":"12","key":"10.1016\/j.schres.2018.05.014_bb0290","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/11537400-000000000-00000","article-title":"Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices","volume":"28","author":"Shi","year":"2010","journal-title":"PharmacoEconomics"},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0295","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0091-6749(86)90325-8","article-title":"Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials","volume":"77","author":"Spector","year":"1986","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.schres.2018.05.014_bb0305","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1536867X0200200206","article-title":"A note on the concordance correlation coefficient","volume":"2","author":"Steichen","year":"2002","journal-title":"Stata J."},{"issue":"7","key":"10.1016\/j.schres.2018.05.014_bb0310","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/jpm.12209","article-title":"Schizophrenia through the carers' eyes: results of a European cross-sectional survey","volume":"22","author":"Svettini","year":"2015","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"issue":"3","key":"10.1016\/j.schres.2018.05.014_bb0315","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","article-title":"Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses","volume":"42","author":"Thompson","year":"2000","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2018.05.014_bb0320","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiat."},{"issue":"11","key":"10.1016\/j.schres.2018.05.014_bb0325","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2471\/BLT.09.067231","article-title":"Developing the World Health Organization disability assessment schedule 2.0","volume":"88","author":"\u00dcst\u00fcn","year":"2010","journal-title":"Bull. World Health Organ."},{"issue":"4","key":"10.1016\/j.schres.2018.05.014_bb0330","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/schbul\/sbj075","article-title":"Defining and assessing adherence to oral antipsychotics: a review of the literature","volume":"32","author":"Velligan","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.schres.2018.05.014_bb0335","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1176\/ps.2007.58.9.1187","article-title":"Relationships among subjective and objective measures of adherence to oral antipsychotic medications","volume":"58","author":"Velligan","year":"2007","journal-title":"Psychiatr. Serv."},{"issue":"Suppl. 4","key":"10.1016\/j.schres.2018.05.014_bb0340","first-page":"1","article-title":"Expert consensus panel on adherence problems in serious and persistent mental illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.05.014_bb0345","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pra.0000367776.96012.ca","article-title":"Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines","volume":"16","author":"Velligan","year":"2010","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.schres.2018.05.014_bb0350","series-title":"Patient Preference and Adherence","first-page":"449","article-title":"Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness","volume":"11","author":"Velligan","year":"2017"},{"issue":"3","key":"10.1016\/j.schres.2018.05.014_bb0355","first-page":"182","article-title":"Management and services for psychosis in People's Republic of China in 2014","volume":"49","author":"Wang","year":"2016","journal-title":"Zhong Hua Jing Shen Ke Za Zhi"},{"key":"10.1016\/j.schres.2018.05.014_bb0360","first-page":"1","article-title":"A proposal for quality standards for measuring medication adherence in research","author":"Williams","year":"2013","journal-title":"AIDS Behav."},{"issue":"2","key":"10.1016\/j.schres.2018.05.014_bb0365","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.schres.2011.11.008","article-title":"Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia","volume":"134","author":"Yang","year":"2012","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2018.05.014_bb0370","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.pec.2017.02.001","article-title":"Medication adherence: a practical measurement selection guide using case studies","volume":"100","author":"Zullig","year":"2017","journal-title":"Patient Educ. Couns."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418302718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418302718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T14:47:20Z","timestamp":1604328440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418302718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":67,"alternative-id":["S0920996418302718"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.05.014","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}